TrialBritish journal of cancer2006

Vinflunine: a new active drug for second-line treatment of advanced breast cancer. Results of a phase II and pharmacokinetic study in patients progressing after first-line anthracycline/taxane-based chemotherapy.

M Campone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.